Senior insider sale
XERIS BIOPHARMA HOLDINGS, INC. — senior position signals high conviction
$88.3K
15K shares
What this filing means
JOHNSON JOHN plans to sell 15K shares of XERIS BIOPHARMA HOLDINGS, INC. valued at approximately $88.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/4/2026ACC: 0001950047-26-005663
Director
Since Oct 2021
15K
Shares to sell
$88.3K
Approx. market value
15K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
6/3/2026
15KTotal acquired15K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/3/2026 | Restricted Stock Units N/A | 15K | — |
| Total | 15K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
15K
Market value
$88.3K
6/4/2026
Total
Units
15K
Value
$88.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/4/2026 | 15K | $88.3K | NASDAQ | Planned |
| Total | 15K | $88.3K | ||